Inventor · disambiguated record
David Gutmann
Also filed as: GUTMANN DAVID · GUTMANN DAVID H
5 granted patents·3 pending applications·13 citations·filing 1991–2022
72Inventor score
Top patents by PatentIndex Score
8 records- 0174US8101606B2Neurofibromin pathway modulatorsGUTMANN DAVID·Filed 2008·Granted Jan 24, 2012·1 cites·6 claims
- 0262US11085933B2Neurofibromin/dopamine signaling as a biomarker for cognitive and behavioral problems in children with neurofibromatosis type 1 (NF1 )UNIV WASHINGTON·Filed 2019·Granted Aug 10, 2021·0 cites·19 claims
- 0356US12280060B2Methods of treating cancer using neuronal activity inhibiting agentsGUTMANN DAVID·Filed 2022·Granted Apr 22, 2025·0 cites·8 claims
- 0452US2023189773A1Engineered cells, animal models, and uses thereof for modeling low grade glioma (lgg)GUTMANN DAVID·Filed 2022·Application pending·0 cites
- 0546US5859195ANeurofibromatosis geneUNIV MICHIGAN·Filed 1995·Granted Jan 12, 1999·9 cites·18 claims
- 0646US2007004767A1Methods for treating neurofibromatosis 1GUTMANN DAVID H·Filed 2006·Application pending·0 cites
- 0746US2016370383A1Neurofibromin/dopamine signaling as a biomarker for cognitive and behavioral problems in children with neurofibromatosis type 1 (nf1)UNIV WASHINGTON·Filed 2016·Application pending·0 cites
- 0830US6238861B1Neurofibromatosis geneUNIV MICHIGAN·Filed 1991·Granted May 29, 2001·3 cites·26 claims
Join the waitlist — get patent alerts
Get an alert when David Gutmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →